CMS Balance Model: How Medicare's New GLP-1 Pilot Works (April 2026)
CMS's new Balance Model launches July 2026 as Medicare's first value-based GLP-1 coverage pilot. Here's what Part D patients need to know about eligibility and costs.
CMS launched the Balance Model pilot in April 2026, a new Medicare framework for GLP-1 weight-loss reimbursement. The structure is a meaningful change from previous all-or-nothing coverage decisions.
Key takeaways
- Medicare patients with BMI 30+ and one weight-related comorbidity may now qualify
- Reimbursement is tied to outcomes — sustained 5%+ weight loss at 6 months
- Initial pilot is limited to selected MA plans; broader rollout depends on year-one outcomes
- Patients still pay copays; the model reduces total Medicare cost, not patient out-of-pocket
How the model works
The Balance Model ties prescribing decisions to a baseline metabolic assessment and a 6-month review. Patients who hit a 5% weight-loss threshold continue with full coverage; those who do not are evaluated for medication switch, dose adjustment, or therapy discontinuation.
It is closer to how oncology and cardiology already manage chronic-disease drug coverage than to how weight-loss medication has historically been handled.
Eligibility and sign-up
Medicare beneficiaries enrolled in participating MA plans can ask their primary care provider about Balance Model evaluation. Original Medicare beneficiaries are not yet eligible. Plans are publishing eligibility criteria on their member portals as the pilot expands.